Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modulation of human eosinophil polymorphonuclear leukocyte migration and function

E J Goetzl

    The American Journal of Pathology
    |November 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Lenalidomide enhancement of human T cell functions in human immunodeficiency virus (HIV)-infected and HIV-negative CD4 T lymphocytopenic patients.

    Clinical and experimental immunology·2012
    Same author

    First international conference on lysophospholipids and related bioactive lipids in biology and disease sponsored by the Federation of American Societies of Experimental Biology.

    TheScientificWorldJournal·2003
    Same author

    Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC(2) receptor for vasoactive intestinal peptide.

    Proceedings of the National Academy of Sciences of the United States of America·2001
    Same author

    Allergic diathesis in transgenic mice with constitutive T cell expression of inducible vasoactive intestinal peptide receptor.

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2001
    Same author

    The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes.

    Journal of molecular and cellular cardiology·2001
    Same author

    Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells.

    Journal of the National Cancer Institute·2001
    Same journal

    Lxrα Deficiency Primes Retinal Degeneration, but Aging Drives Disease Severity.

    The American journal of pathology·2026
    Same journal

    MYC is functionally required in both normal and neoplastic Meibomian glands.

    The American journal of pathology·2026
    Same journal

    Fumaric Acid Esters as Modulators of Ocular Inflammation and Angiogenesis.

    The American journal of pathology·2026
    Same journal

    Krüppel-like factor 5 inhibition rescues cavernous nerve-injured erectile dysfunction by preventing phenotypic switch and mitochondrial dysfunction-dependent apoptosis in corpus cavernosum smooth muscle cells.

    The American journal of pathology·2026
    Same journal

    APOE4 as a Modifier of Chemotherapy Response.

    The American journal of pathology·2026
    Same journal

    Spatial Pathobiology in the Omics Era: Transforming Modern Pathology.

    The American journal of pathology·2026
    See all related articles

    Eosinophil chemotaxis, crucial for host defense, is regulated by four distinct levels. These include stimulus generation, intrinsic leukocyte activity, inhibitor/inactivator actions, and eosinophil responsiveness modulation.

    Area of Science:

    • Immunology
    • Cell Biology
    • Allergy and Inflammation Research

    Background:

    • Eosinophil migration is a key component of immune responses, particularly in hypersensitivity reactions.
    • Chemotactic factors, derived from various immunologic pathways, initiate eosinophil recruitment.
    • Understanding eosinophil regulation is vital for addressing inflammatory diseases.

    Purpose of the Study:

    • To elucidate the multi-level regulatory mechanisms governing eosinophil chemotaxis.
    • To identify key factors and pathways involved in controlling eosinophil migration and activity.

    Main Methods:

    • Analysis of immunologic pathways generating eosinophil chemotactic stimuli (e.g., complement products, mast cell peptides).
    • Evaluation of chemotactic stimuli selectivity and inactivation processes (e.g., enzyme degradation, peptide inhibition).

    Related Experiment Videos

  • Investigation of factors modulating eosinophil responsiveness, including deactivation, inhibitors, and enhancers.

    • Main Results:

    • Eosinophil chemotaxis is regulated at four distinct levels: stimulus generation, intrinsic activity, inactivation, and responsiveness modulation.
    • Eosinophil Chemotactic Factor of Anaphylaxis (ECF-A) exhibits selective action, while its activity is suppressed by specific peptide substituents.
    • Various factors, including inhibitors (NIF, histamine) and enhancers (histamine, ascorbate), modulate eosinophil responsiveness.

    Conclusions:

    • Eosinophil migration is a tightly regulated process involving multiple interacting mechanisms.
    • Eosinophils contribute to host defense by modulating inflammatory mediators at reaction sites.
    • This intricate regulation allows for timely and specific immune responses, preventing tissue damage.